218 related articles for article (PubMed ID: 26146842)
41. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746
[TBL] [Abstract][Full Text] [Related]
42. Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370.
Asojo OA; Afonina E; Gulnik SV; Yu B; Erickson JW; Randad R; Medjahed D; Silva AM
Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2001-8. PubMed ID: 12454457
[TBL] [Abstract][Full Text] [Related]
43. Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum.
Bhaumik P; Xiao H; Parr CL; Kiso Y; Gustchina A; Yada RY; Wlodawer A
J Mol Biol; 2009 May; 388(3):520-40. PubMed ID: 19285084
[TBL] [Abstract][Full Text] [Related]
44. The protonation state of the catalytic aspartates in plasmepsin II.
Friedman R; Caflisch A
FEBS Lett; 2007 Aug; 581(21):4120-4. PubMed ID: 17689534
[TBL] [Abstract][Full Text] [Related]
45. Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity.
Ersmark K; Feierberg I; Bjelic S; Hamelink E; Hackett F; Blackman MJ; Hultén J; Samuelsson B; Aqvist J; Hallberg A
J Med Chem; 2004 Jan; 47(1):110-22. PubMed ID: 14695825
[TBL] [Abstract][Full Text] [Related]
46. Role of plasmepsin V in export of diverse protein families from the Plasmodium falciparum exportome.
Boddey JA; Carvalho TG; Hodder AN; Sargeant TJ; Sleebs BE; Marapana D; Lopaticki S; Nebl T; Cowman AF
Traffic; 2013 May; 14(5):532-50. PubMed ID: 23387285
[TBL] [Abstract][Full Text] [Related]
47. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
Gutiérrez-de-Terán H; Nervall M; Ersmark K; Liu P; Janka LK; Dunn B; Hallberg A; Aqvist J
Biochemistry; 2006 Sep; 45(35):10529-41. PubMed ID: 16939205
[TBL] [Abstract][Full Text] [Related]
48. Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screening.
Meissner KA; Kronenberger T; Maltarollo VG; Trossini GHG; Wrenger C
Chem Biol Drug Des; 2019 Mar; 93(3):300-312. PubMed ID: 30320974
[TBL] [Abstract][Full Text] [Related]
49. Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man.
Dame JB; Yowell CA; Omara-Opyene L; Carlton JM; Cooper RA; Li T
Mol Biochem Parasitol; 2003 Aug; 130(1):1-12. PubMed ID: 14550891
[TBL] [Abstract][Full Text] [Related]
50. Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum.
Bonilla JA; Moura PA; Bonilla TD; Yowell CA; Fidock DA; Dame JB
Int J Parasitol; 2007 Mar; 37(3-4):317-27. PubMed ID: 17207486
[TBL] [Abstract][Full Text] [Related]
51. The nepenthesin insert in the Plasmodium falciparum aspartic protease plasmepsin V is necessary for enzyme function.
Polino AJ; Miller JJ; Bhakat S; Mukherjee S; Bobba S; Bowman GR; Goldberg DE
J Biol Chem; 2022 Sep; 298(9):102355. PubMed ID: 35952758
[TBL] [Abstract][Full Text] [Related]
52. Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations.
Xu Y; Li MJ; Greenblatt H; Chen W; Paz A; Dym O; Peleg Y; Chen T; Shen X; He J; Jiang H; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2012 Jan; 68(Pt 1):13-25. PubMed ID: 22194329
[TBL] [Abstract][Full Text] [Related]
53. Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum.
Banerjee R; Francis SE; Goldberg DE
Mol Biochem Parasitol; 2003 Jul; 129(2):157-65. PubMed ID: 12850260
[TBL] [Abstract][Full Text] [Related]
54. High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor.
Nezami A; Kimura T; Hidaka K; Kiso A; Liu J; Kiso Y; Goldberg DE; Freire E
Biochemistry; 2003 Jul; 42(28):8459-64. PubMed ID: 12859191
[TBL] [Abstract][Full Text] [Related]
55. Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax.
Hodder AN; Christensen J; Scally S; Triglia T; Ngo A; Birkinshaw RW; Bailey B; Favuzza P; Dietrich MH; Tham WH; Czabotar PE; Lowes K; Guo Z; Murgolo N; Lera Ruiz M; McCauley JA; Sleebs BE; Olsen D; Cowman AF
Structure; 2022 Jul; 30(7):947-961.e6. PubMed ID: 35460613
[TBL] [Abstract][Full Text] [Related]
56. Naturally-occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium falciparum.
Tyas L; Gluzman I; Moon RP; Rupp K; Westling J; Ridley RG; Kay J; Goldberg DE; Berry C
FEBS Lett; 1999 Jul; 454(3):210-4. PubMed ID: 10431809
[TBL] [Abstract][Full Text] [Related]
57. Yield improvement and enzymatic dissection of Plasmodium falciparum plasmepsin V.
Loymunkong C; Sittikul P; Songtawee N; Wongpanya R; Boonyalai N
Mol Biochem Parasitol; 2019 Jul; 231():111188. PubMed ID: 31108131
[TBL] [Abstract][Full Text] [Related]
58. Active site specificity of plasmepsin II.
Westling J; Cipullo P; Hung SH; Saft H; Dame JB; Dunn BM
Protein Sci; 1999 Oct; 8(10):2001-9. PubMed ID: 10548045
[TBL] [Abstract][Full Text] [Related]
59. 2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity.
Rasina D; Stakanovs G; Borysov OV; Pantelejevs T; Bobrovs R; Kanepe-Lapsa I; Tars K; Jaudzems K; Jirgensons A
Bioorg Med Chem; 2018 May; 26(9):2488-2500. PubMed ID: 29636223
[TBL] [Abstract][Full Text] [Related]
60. Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte.
Russo I; Babbitt S; Muralidharan V; Butler T; Oksman A; Goldberg DE
Nature; 2010 Feb; 463(7281):632-6. PubMed ID: 20130644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
